Filings For: Alzamend Neuro, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics
GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Alzamend Neuro, Inc. (ALZN) 7/22/2026 4:41:40 PM Micro View Financials 10-K SEC Y 2026 ending: 4/30/2026 Assets $2,079,363 EPS -$2.63
Alzamend Neuro, Inc. (ALZN) 3/11/2026 4:47:30 PM Micro View Financials 10-Q SEC 3Q 2026 ending: 1/31/2026 Assets $4,041,833 EPS -$0.58
Alzamend Neuro, Inc. (ALZN) 2/26/2026 5:13:42 PM   View Proxy SEC Y 2025
Alzamend Neuro, Inc. (ALZN) 12/9/2025 4:46:57 PM Micro View Financials 10-Q SEC 2Q 2026 ending: 10/31/2025 Assets $5,091,684 EPS -$0.30
Alzamend Neuro, Inc. (ALZN) 9/10/2025 4:42:15 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 7/31/2025 Assets $6,326,751 EPS -$1.28
Alzamend Neuro, Inc. (ALZN) 7/23/2025 4:32:06 PM   View Financials Earnings SEC Y 2025 Assets $4,602,983 EPS -$10.29 Export Earnings Model
Alzamend Neuro, Inc. (ALZN) 7/22/2025 4:45:41 PM Micro View Financials 10-K SEC Y 2025 ending: 4/30/2025 Assets $4,602,983 EPS -$11.32
Alzamend Neuro, Inc. (ALZN) 3/13/2025 5:01:13 PM   View Proxy SEC Y 2024
Alzamend Neuro, Inc. (ALZN) 3/10/2025 4:43:59 PM Micro View Financials 10-Q SEC 3Q 2025 ending: 1/31/2025 Assets $4,175,634 EPS -$0.19
Alzamend Neuro, Inc. (ALZN) 12/12/2024 4:31:46 PM   View Financials Earnings SEC 2Q 2025 Assets $5,007,718 EPS -$0.40 Export Earnings Model
Alzamend Neuro, Inc. (ALZN) 12/11/2024 4:41:32 PM Micro View Financials 10-Q SEC 2Q 2025 ending: 10/31/2024 Assets $5,007,718 EPS -$0.40
Alzamend Neuro, Inc. (ALZN) 9/11/2024 4:39:31 PM Micro View Financials 10-Q SEC 1Q 2025 ending: 7/31/2024 Assets $1,669,852 EPS -$1.25
Alzamend Neuro, Inc. (ALZN) 7/30/2024 4:48:46 PM Micro View Financials 10-K SEC Y 2024 ending: 4/30/2024 Assets $631,588 EPS -$14.70
Alzamend Neuro, Inc. (ALZN) 5/31/2024 5:01:11 PM   View Proxy SEC Y 2024
Alzamend Neuro, Inc. (ALZN) 3/25/2024 5:35:46 PM Micro View Financials 10-Q SEC 3Q 2024 ending: 1/31/2024 Assets $782,636 EPS -$0.38
Alzamend Neuro, Inc. (ALZN) 3/25/2024 4:46:41 PM   View Proxy SEC Y 2023
Alzamend Neuro, Inc. (ALZN) 12/15/2023 4:46:03 PM Micro View Financials 10-Q SEC 2Q 2024 ending: 10/31/2023 Assets $983,597 EPS -$0.44
Alzamend Neuro, Inc. (ALZN) 9/13/2023 5:29:11 PM Micro View Financials 10-Q SEC 1Q 2024 ending: 7/31/2023 Assets $2,628,005 EPS -$0.04
Alzamend Neuro, Inc. (ALZN) 8/24/2023 4:31:23 PM   View Proxy SEC Y 2023
Alzamend Neuro, Inc. (ALZN) 7/27/2023 5:09:06 PM Micro View Financials 10-K SEC Y 2023 ending: 4/30/2023 Assets $5,915,625 EPS -$0.15
Alzamend Neuro, Inc. (ALZN) 3/31/2023 4:41:19 PM   View Proxy SEC Y 2022
Alzamend Neuro, Inc. (ALZN) 3/16/2023 4:31:21 PM   View Financials Earnings SEC 3Q 2023 Assets $8,501,978 Export Earnings Model
Alzamend Neuro, Inc. (ALZN) 3/15/2023 4:38:34 PM Micro View Financials 10-Q SEC 3Q 2023 ending: 1/31/2023 Assets $8,501,978
Alzamend Neuro, Inc. (ALZN) 12/12/2022 4:46:58 PM Micro View Financials 10-Q SEC 2Q 2023 ending: 10/31/2022 Assets $10,424,876
Alzamend Neuro, Inc. (ALZN) 9/13/2022 4:46:51 PM Micro View Financials 10-Q SEC 1Q 2023 ending: 7/31/2022 Assets $12,210,475
Alzamend Neuro, Inc. (ALZN) 7/19/2022 4:48:14 PM Micro View Financials 10-K SEC Y 2022 ending: 4/30/2022 Assets $14,516,443
Alzamend Neuro, Inc. (ALZN) 3/15/2022 4:40:49 PM Micro View Financials 10-Q SEC 3Q 2022 ending: 1/31/2022 Assets $12,429,116
Alzamend Neuro, Inc. (ALZN) 12/13/2021 4:04:40 PM Micro View Financials 10-Q SEC 2Q 2022 ending: 10/31/2021 Assets $14,500,896
Alzamend Neuro, Inc. (ALZN) 9/13/2021 4:22:06 PM Micro View Financials 10-Q SEC 1Q 2022 ending: 7/31/2021 Assets $16,817,651
Alzamend Neuro, Inc. (ALZN) 7/29/2021 5:32:00 PM Micro View Financials 10-K SEC Y 2021 ending: 4/30/2021 Rev: $1,706 -87.7% Assets $2,912,590